|
TMEM183A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.86510000005558E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75597999999555E-05 |
| Normal-vs-Stage2 |
8.437600E-02 |
| Normal-vs-Stage3 |
4.39520000000693E-05 |
| Normal-vs-Stage4 |
3.48819999995698E-06 |
| Stage1-vs-Stage2 |
4.717800E-01 |
| Stage1-vs-Stage3 |
4.226000E-01 |
| Stage1-vs-Stage4 |
3.007000E-01 |
| Stage2-vs-Stage3 |
2.443200E-01 |
| Stage2-vs-Stage4 |
2.014000E-01 |
| Stage3-vs-Stage4 |
8.714600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01410000000291E-06 |
| Normal-vs-AfricanAmerican |
5.36599999989562E-08 |
| Normal-vs-Asian |
1.459820E-01 |
| Caucasian-vs-AfricanAmerican |
2.813700E-02 |
| Caucasian-vs-Asian |
5.904200E-01 |
| AfricanAmerican-vs-Asian |
9.153600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.69290000485401E-08 |
| Normal-vs-Female |
7.999400E-04 |
| Male-vs-Female |
8.186100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.978170E-03 |
| Normal-vs-Age(41-60Yrs) |
2.92229999976357E-07 |
| Normal-vs-Age(61-80Yrs) |
5.71339999999587E-05 |
| Normal-vs-Age(81-100Yrs) |
5.954600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.754800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.631600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.464600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.214000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.427400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.233600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.183660E-02 |
| Normal-vs-Grade 2 |
8.362200E-04 |
| Normal-vs-Grade 3 |
1.52560999999718E-05 |
| Normal-vs-Grade 4 |
9.49809999983842E-07 |
| Grade 1-vs-Grade 2 |
3.787600E-01 |
| Grade 1-vs-Grade 3 |
8.714800E-01 |
| Grade 1-vs-Grade 4 |
2.054000E-01 |
| Grade 2-vs-Grade 3 |
1.354380E-01 |
| Grade 2-vs-Grade 4 |
8.963600E-03 |
| Grade 3-vs-Grade 4 |
1.838760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.607040E-01 |
| Normal-vs-ccB subtype |
2.98210012239508E-10 |
| ccA subtype-vs-ccB subtype |
1.50310000002207E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.002440E-04 |
| Normal-vs-N1 |
1.983800E-02 |
| N0-vs-N1 |
8.707800E-01 |
|
|
